Is Nail-patella syndrome hereditary?

Nail-patella syndrome is a hereditary genetic condition caused by mutations in the LMX1B gene, which follows an autosomal dominant inheritance pattern. This means an affected individual has a 50% chance of passing the condition to each of their children, regardless of the child's biological sex.

Is Nail-patella syndrome strictly hereditary?

Nail-patella syndrome, also known as hereditary osteo-onychodysostosis, is both genetic and hereditary. It is "genetic" because it is caused by a specific alteration in the DNA sequence of the LMX1B gene. It is "hereditary" because it is passed down through generations within families. While most cases are inherited from an affected parent, approximately 20% of cases are considered de novo, meaning the mutation occurs spontaneously in the affected individual for the first time, with no family history of the disorder.

What is the inheritance pattern of Nail-patella syndrome?

Nail-patella syndrome follows an autosomal dominant inheritance pattern. In clinical genetics, "autosomal" means the gene is located on one of the non-sex chromosomes, and "dominant" means that only one copy of the mutated gene is required to express the condition. Because the LMX1B gene is essential for the development of limbs, kidneys, and eyes, even a single mutation can lead to the characteristic clinical features of the syndrome.

What is the risk for children of an affected parent?

When one parent has Nail-patella syndrome, each pregnancy carries a 50% statistical probability of inheriting the LMX1B mutation. It is important to note that the clinical severity of Nail-patella syndrome can vary significantly—a phenomenon known as variable expressivity—even among family members who share the exact same genetic mutation. This means one family member might have mild nail abnormalities, while another might experience more severe skeletal or renal issues.

How is genetic testing and counseling utilized?

Genetic testing for Nail-patella syndrome involves molecular analysis of the LMX1B gene to identify pathogenic variants. This testing is recommended for individuals presenting with classic symptoms to confirm the diagnosis and provide clarity for family planning. Genetic counseling is strongly advised for affected individuals and their partners to discuss the following:

• Risk Assessment: Understanding the 50% recurrence risk for future children.


• Prenatal Options: Discussing reproductive choices such as preimplantation genetic testing (PGT) during IVF or prenatal diagnosis via chorionic villus sampling (CVS) or amniocentesis.


• Family Screening: Identifying other family members who may be at risk but are currently asymptomatic or have undiagnosed features.


• Psychosocial Support: Connecting with the 413 members of the DiseaseMaps.org community who share lived experiences with Nail-patella syndrome.

Next steps

• Consult with a clinical geneticist or a genetic counselor to discuss your specific family history and testing options.


• Request a referral to a nephrologist or orthopedist to screen for common manifestations of Nail-patella syndrome.


• Join the DiseaseMaps.org community to connect with others currently navigating life with Nail-patella syndrome.


• If you are planning a pregnancy, speak with a reproductive specialist about preimplantation genetic testing (PGT).

Medical Disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always consult with your physician regarding your specific health needs.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases (GARD) Information Center: Nail-patella syndrome.


• Orphanet: Rare disease database entry for Nail-patella syndrome (ORPHA:638).


• Online Mendelian Inheritance in Man (OMIM): Entry #161200, Nail-patella syndrome.


• Nail-Patella Syndrome Foundation (NPSF): Resources for patients and families.